NEWS & EVENTS
NIBIB is calling on engineers, biologists, computer scientists, and information technologists across academia, industry, and non-profit sectors to submit proposals for high-risk, high-reward research that seeks to integrate basic science, clinical practice, and technology to solve critical challenges in health and healthcare.
A look at how researchers use nature as the basis for bioengineering discoveries includes the work by NIBIB grantee Bob Langer at MIT and his colleague Jeffrey Karp at Brigham and Women’s Hospital on quick release adhesive for the fragile skin of babies and the elderly. Read the full article from The Washington Post.
Genomic screening in combination with MRI imaging has enabled NIBIB-funded researchers at the University of California Los Angeles (UCLA) to discover genetic varients that affect the brain’s wiring. The findings suggest that a specific gene (SPON1) variant and new neurogenetic pathway have links to dementia severity. Additional information can be found from Proceedings of the National Academy of Sciences: Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity.
The American Institute for Medical and Biological Engineering (AIMBE) honored eight NIBIB grantees for their significant accomplishments and innovation in medical and biological engineering at the AIMBE annual meeting held February 17-19, 2013 in Washington, DC. AIMBE fellows are nominated by their peers for their outstanding contributions in research, industrial practice and/or education, and represent the top 2% of the medical and bioengineering community. A total of 81 new Fellows were inducted this year.